Zymeworks Inc
Price
FilingsNewest: 8-K, Material agreementSep 23 →InsidersNo open-market buys. 4 insiders sold $4.7M, 0 of 10 sales on a 10b5-1 plan.→HoldersEcoR1 Capital 32.2%Rubric 9.8%BlackRock 6.0%→PeersClosest companies: AGEN, VIR, STRO→
From the filings
Figures
- Revenue
- $37.1Mlast 12 months
- Net income
- −$150.0Mlast 12 months
- Operating cash flow
- −$75.3Mlast 12 months
- Cash and equivalents
- $179.4Mat the last balance sheet
- Shares outstanding
- 71.4M shareson issue